US FDA new drug expedited review strategies and its implications for China
YUAN Lin;SHAO Ming-li;Shenyang Pharmaceutical University;

..............page:2401-2404+2409

Thinking and strategy on standard management of traditional Chinese medicine extracts
CONG Luo-luo;WU Bin;ZHANG Jian-wu;SHAO Ming-li;School of International Pharmaceutical Business;China Pharmaceutical University;Beijing Food and Drug Administration;

..............page:2405-2409

Suggestions for clinical trial registration and information sharing in China
ZONG Xin;DONG Jiang-ping;TAO Xiu-mei;Information Center;China Food and Drug Administration;Drug Registration Department;China Food and Drug Administration;Beijing Nuokangda Pharmceutical Technology Co.;Ltd.;

..............page:2410-2413

Impacts of pharmaceutical industry innovation on patent output:an analysis based on data of three five-year plans in East China
HUO Yan-fei;YI Ba-xian;WANG Guang-ping;SHI Sheng-yi;CHEN Ying;LI Chi-rong;China State Institute of Pharmaceutical Industry;Shanghai Institute for Food and Drug Safety;China National Pharmaceutical Group Corporation;Airforce Convalescent Zone;Hangzhou Sanatorium;

..............page:2414-2419+2433

Pharmaceutical procurement mode in Germany:the primary role of community pharmacy
DONG Guo-qing;GUAN Hai-jing;LI Qian;LIU Guo-en;SUN Li-hua;School of Business Administration;Shenyang Pharmaceutical University;PKU China Center for Health Economic Research;School of International Pharmaceutical Business;China Pharmaceutical University;

..............page:2420-2424

Status of quality specification of highly toxic medicinal materials and discussion on related issues
ZHOU Yue-hua;XU Zeng-lai;LU Jin-cai;Center for Drug Evaluation;China Food and Drug Administration;Institute of Botany;Chinese Acadamy of Sciences of Jiangsu Province;Shenyang Pharmaceutical University;

..............page:2425-2433

Comparison of guidelines for new drug safety pharmacology studies between China and European Union
CHEN Yu-cai;ZHANG Hui-fang;FANG Lian-hua;DU Guan-hua;Beijing Key Laboratory of Drug Targets Identification and Drug Screening;Institute of Materia Medica;Chinese Academy of Medical Sciences and Peking Union Medical College;

..............page:2434-2436

Progress in epidemiology and treatment of benign prostatic hyperplasia and erectile dysfunction
ZHOU Yan;CHENG Jing;WANG Jin;TIAN Yu-wei;QI Qu;LI Jia-kui;WU Yong-qian;Xuan Zhu Pharma Co.;Ltd.;

..............page:2437-2447+2466

Progress in toxicokinetics research of traditional Chinese medicines
GAO Fang-yuan;YUAN Bo-jun;MA Xiu-juan;XIA Zhen-na;LU Guo-cai;Center for Evaluation of Drug Safety;Second Military Medical University;

..............page:2448-2452+2458

Research progress in in vitro models for assessing drug transport across blood-brain barrier
ZHANG Jun-ying;DIAO Jin-fu;L Qing-lin;WU Chun-yong;Department of Pharmaceutics of Traditional Chinese Medicine;China Pharmaceutical University;Department of Neurosurgery;The General Hospital of Chinese People’s Armed Police Forces;Experimental Center of Natural Medicine;China Pharmaceutical University;Department of Pharmaceutical Analysis;China Pharmaceutical University;Key Laboratory of Drug Quality Control and Pharmacovigilance;Ministry of Education;

..............page:2453-2458

Influence factors of the pulmonary drug delivery process of dry powder inhalers
TIAN Pei;YANG Zhi-qiang;WANG Xing-lin;ZHAO Ya-hui;Tianjin Medical University;Tianjin Institute of Pharmaceutical Research Company Limited;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;

..............page:2459-2466

Application and research situation of direct powder tableting technology and excipients
LI Jin-zhi;FENG Jin-rui;HE Tian;LIN Xiao;Shanghai University of Traditional Chinese Medicine;

..............page:2467-2470+2498

Advances in research on the relationship between Wnt / β-catenin signal pathway and systemic sclerosis
BIAN Hua;HAN Li;YANG Lei;Medical College of Nanyang Institute of Technology;

..............page:2471-2475

fda dui ai bo wei gong si bing gan yao wu cun zai yan zhong gan sun hai feng xian ti chu jing gao

..............page:2475

Safety and tolerability of combination of retagliptin and valsartan in healthy volunteers
YONG Xiao-lan;LI Nan;FENG Shi-yin;WANG Lan-tian;KANG Hui;Department of Clinical Pharmacy;Chengdu Military General Hospital;

..............page:2476-2479

shi jie shou ge ji yu rong liu bing du de kang ai yao wu imlygic huo de ou meng tui jian pi zhun

..............page:2479

Safety and efficacy of low-dose ticagrelor in patients with unstable angina pectoris and non-revascularization
LI Kang-bo;XU Ying-jun;HAN Quan-le;College of Public Health;Tangshan Worker’s Hospital;North China University of Science and Technology;Department of Cardiology;Tangshan Worker’s Hospital;North China University of Science and Technology;

..............page:2480-2484

Structure-activity relationship analysis of 12-lipoxygenase inhibitors based on Topomer CoMFA and molecular docking
AN Chun-hong;SHU Mao;WEN Xiao-rong;ZAI Xiao-li;School of Pharmacy and Bioengineering;Chongqing University of Technology;

..............page:2485-2488+2506

Effect of Lagotis brevituba Maxim. extract in reducing uric acid level in hyperuricemia mice and it’s mechanism
ZENG Jin-xiang;XU Bing-bing;LI Min;LI Xue-wei;ZHU Ji-xiao;WANG Xiao-yun;ZHONG Guo-yue;LUO Guang-ming;ZHU Yu-ye;WANG Juan;The Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine;Jiangxi University of Traditional Chinese Medicine;

..............page:2489-2493

Effect of decoction of burdock root on erectile dysfunction in rat models
YAO Jia;CHEN Kao-shan;YU Li-zhen;LI Li-hua;Jining First People’s Hospital;School of Life Sciences;Shangdong University;Wannan Medical College;

..............page:2494-2498

Synthesis of an anti-type 2 diabetes mellitus drug,sitagliptin
WU Ting;LIU Yuan;DONG Hong-xin;XIA Chao;SHI Jin-cheng;School of Pharmaceutical Sciences;Nanjing University of Technology;Jiangsu Provincial Institute of Material Co.;Nanjing University of Technology;

..............page:2499-2501+2510

In vitro releasing behavior of methazolamide nanoparticle eye drop and its ocular hypotensive effect in rabbits
LI Guang-yuan;LOU Jian-shi;CHEN Bin;LI Nan;WANG Xiao-hui;LIU Pei-li;ZHU Jun-mei;Department of Pharmacology;Tianjin Medical University;Medical Biological Material Supervision and Research Center;Tianjin Institute of Medical and Pharmaceutical Sciences;

..............page:2502-2506

Preparation and quality control of freeze-dried products of Cys-Annexin V for apoptosis imaging
JIANG Quan-fu;LU Chun-xiong;HU Min-jin;YU Hui-xin;HUA Zi-chun;Key Laboratory of Nuclear Medicine;Ministry of Health;Jiangsu Key Laboratory of Molecular Nuclear Medicine;Jiangsu Institute of Nuclear Medicine;Jiangsu Target Pharma Laboratories Inc.;Changzhou High-Tech Research Institute of Nanjing University;The State Key Laboratory of Pharmaceutical Biotechnology;Nanjing University;

..............page:2507-2510

Optimization of water extraction process of polysaccharides from Saccharum Alhagi based on artificial neural networks-genetic algorithms
WANG Wei;LIU Wen-hui;CHANG Jun-min;HALMURAT Upur;Uyghur Medical College;Xinjiang Medical University;College of Information Science and Technology;Xinjiang Education Institute;College of Pharmacy;Xinjiang Medical University;

..............page:2511-2515+2520

Determination of related substances and content of icotinib hydrochloride cream by HPLC
GUO Chun-zhe;WANG Dong-kai;HU Yun-yan;CAO Hong;LI Hong-zhi;TIAN Li-li;Shenyang Pharmaceutical University;Betta Pharmaceuticals Co.;Ltd.;

..............page:2516-2520

2014-2015 nian xin yao shen bao yu shen ping ji shu lun wen xuan ji zheng ding qi shi

..............page:2522